Mesoblast Ltd
Nasdaq: MESO
- Raised $6.5 million (2020)
- 34 clinical trials, 2 active
Life science companies
Explore 34,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Revvity, Inc.
NYSE: RVTY
- Raised $2.2 billion (2021)
- FDA-cleared or approved devices
Venus Concept Inc.
OTC: VERO
- Raised $1.5 million (2026)
- 34 clinical trials, 2 active
Palvella Therapeutics, Inc.
Nasdaq: PVLA
- Raised $9.7 million (2022)
- 16 clinical trials, 5 active
- Founded 2013
Anebulo Pharmaceuticals, Inc.
OTC: ANEB
- Raised $15 million (2024)
- 3 clinical trials, 1 active
- Founded 2020
BioAge Labs, Inc.
Nasdaq: BIOA
- Raised $194 million (2024)
- 7 clinical trials, 2 active
CRISPR Therapeutics AG
Nasdaq: CRSP
- Raised $1 million (2020)
- 20 clinical trials, 10 active
- Founded 2013
DiaMedica Therapeutics Inc.
Nasdaq: DMAC
- Raised $30 million (2025)
- 7 clinical trials, 1 active
Dynocardia, Inc.
- Raised $4.8 million (2025)
- 1 clinical trial, 1 active
- Research grants: $10 million
- Founded 2018
Immunic, Inc.
Nasdaq: IMUX
- Raised $200 million (2026)
- 7 clinical trials, 3 active
Kyverna Therapeutics, Inc.
Nasdaq: KYTX
- Raised $152 million (2023)
- 7 clinical trials, 3 active
Mereo BioPharma Group plc
Nasdaq: MREO
- Raised $70 million (2020)
- Founded 2015
Niagen Bioscience, Inc.
Nasdaq: NAGE
- Raised $3.1 million (2022)
- 5 clinical trials, 2 active
- Founded 2008
PolyPid Ltd.
Nasdaq: PYPD
- Raised $27 million (2025)
- 7 clinical trials
Pulmatrix, Inc.
Nasdaq: PULM
- Raised $1 million (2026)
- 15 clinical trials
- Founded 2013
SELLAS Life Sciences Group, Inc.
Nasdaq: SLS
- Raised $18 million (2024)
- 9 clinical trials, 2 active
Voyager Therapeutics, Inc.
Nasdaq: VYGR
- Raised $20 million (2024)
- 7 clinical trials, 2 active
- Founded 2013
HeartBeam, Inc.
Nasdaq: BEAT
- Raised $200,000 (2019)
- 3 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2015
SentiAR, Inc.
- Raised $1.5 million (2026)
- FDA-cleared or approved devices
- Research grants: $4.4 million
- Founded 2017
GigaGen, Inc.
- Raised $36 million (2017)
- 3 clinical trials, 2 active
- Research grants: $16 million
Showing 560 of 34,266 companies
Load morePublished company profiles only; counts update daily. Data licences